{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:39:15Z","timestamp":1793947155878,"version":"4.8.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical University of Bialystok","id":[{"id":"https:\/\/ror.org\/00y4ya841","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"DOI":"10.1007\/s11154-026-10098-7","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:10:07Z","timestamp":1792635007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Glucose-dependent insulinotropic polypeptide (GIP) signaling in visceral and subcutaneous adipose tissue: implications for obesity and metabolic disease\u2014a narrative review with a structured literature search"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3504-951X","authenticated-orcid":false,"given":"Joanna","family":"Smarkusz-Zarzecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelina","family":"Radziszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof Ksawery","family":"Gofron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucyna","family":"Ostrowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"10098_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.metabol.2019.04.014","volume":"96","author":"JJ Holst","year":"2019","unstructured":"Holst JJ. The incretin system in healthy humans: The role of GIP and GLP-1. Metabolism. 2019;96:46\u201355.","journal-title":"Metabolism"},{"key":"10098_CR2","doi-asserted-by":"publisher","first-page":"170749","DOI":"10.1016\/j.peptides.2022.170749","volume":"151","author":"A Mayendraraj","year":"2022","unstructured":"Mayendraraj A, Rosenkilde MM, Gasbjerg LS. GLP-1 and GIP receptor signaling in beta cells - A review of receptor interactions and co-stimulation. Peptides. 2022;151:170749.","journal-title":"Peptides"},{"issue":"2","key":"10098_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.2040-1124.2012.00196.x","volume":"3","author":"CH McIntosh","year":"2012","unstructured":"McIntosh CH, Widenmaier S, Kim SJ. Glucose-dependent insulinotropic polypeptide signaling in pancreatic \u03b2-cells and adipocytes. J Diabetes Investig. 2012;3(2):96\u2013106.","journal-title":"J Diabetes Investig"},{"issue":"9","key":"10098_CR4","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.2337\/dbi21-0001","volume":"70","author":"M Fukuda","year":"2021","unstructured":"Fukuda M. The Role of GIP Receptor in the CNS for the Pathogenesis of Obesity. Diabetes. 2021;70(9):1929\u201337.","journal-title":"Diabetes"},{"key":"10098_CR5","doi-asserted-by":"publisher","first-page":"170178","DOI":"10.1016\/j.peptides.2019.170178","volume":"125","author":"MB Christensen","year":"2020","unstructured":"Christensen MB, Gasbjerg LS, Heimb\u00fcrger SM, et al. GIP\u2019s involvement in the pathophysiology of type 2 diabetes. Peptides. 2020;125:170178.","journal-title":"Peptides"},{"issue":"3","key":"10098_CR6","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.3390\/ijms24032684","volume":"24","author":"D Martelli","year":"2023","unstructured":"Martelli D, Brooks VL. Leptin Increases: Physiological Roles in the Control of Sympathetic Nerve Activity, Energy Balance, and the Hypothalamic-Pituitary-Thyroid Axis. Int J Mol Sci. 2023;24(3):2684.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10098_CR7","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.2337\/db05-1322","volume":"55","author":"MJ Yoon","year":"2006","unstructured":"Yoon MJ, Lee GY, Chung JJ, et al. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes. 2006;55(9):2562\u201370.","journal-title":"Diabetes"},{"issue":"5","key":"10098_CR8","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1089\/jir.2013.0078","volume":"34","author":"C Shi","year":"2014","unstructured":"Shi C, Zhu L, Chen X, et al. IL-6 and TNF-\u03b1 induced obesity-related inflammatory response through transcriptional regulation of miR-146b. J Interferon Cytokine Res. 2014;34(5):342\u20138.","journal-title":"J Interferon Cytokine Res"},{"issue":"10","key":"10098_CR9","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1007\/s00125-012-2639-5","volume":"55","author":"BM Kaess","year":"2012","unstructured":"Kaess BM, Pedley A, Massaro JM, et al. The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk. Diabetologia. 2012;55(10):2622\u201330.","journal-title":"Diabetologia"},{"issue":"3","key":"10098_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.regpep.2007.02.006","volume":"142","author":"N Rudovich","year":"2007","unstructured":"Rudovich N, Kaiser S, Engeli S, et al. GIP receptor mRNA expression in different fat tissue depots in postmenopausal non-diabetic women. Regul Pept. 2007;142(3):138\u201345.","journal-title":"Regul Pept"},{"issue":"5","key":"10098_CR11","doi-asserted-by":"publisher","first-page":"E908","DOI":"10.1210\/jc.2013-3350","volume":"99","author":"V Ceperuelo-Mallafr\u00e9","year":"2014","unstructured":"Ceperuelo-Mallafr\u00e9 V, Duran X, Pach\u00f3net G, et al. Disruption of GIP\/GIPR axis in human adipose tissue is linked to obesity and insulin resistance. J Clin Endocrinol Metab. 2014;99(5):E908\u201319.","journal-title":"J Clin Endocrinol Metab"},{"key":"10098_CR12","doi-asserted-by":"publisher","first-page":"643144","DOI":"10.3389\/fimmu.2021.643144","volume":"12","author":"I Efimova","year":"2021","unstructured":"Efimova I, Steinberg I, Zvibel I, et al. GIPR Signaling in Immune Cells Maintains Metabolically Beneficial Type 2 Immune Responses in the White Fat From Obese Mice. Front Immunol. 2021;12:643144.","journal-title":"Front Immunol"},{"issue":"1","key":"10098_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00125-013-3066-y","volume":"57","author":"J Naukkarinen","year":"2014","unstructured":"Naukkarinen J, Heinonen S, Hakkarainen A, et al. Characterising metabolically healthy obesity in weight-discordant monozygotic twins. Diabetologia. 2014;57(1):167\u201376.","journal-title":"Diabetologia"},{"issue":"6","key":"10098_CR14","doi-asserted-by":"publisher","first-page":"7520","DOI":"10.1096\/fj.201902703R","volume":"34","author":"R Guzm\u00e1n-Ruiz","year":"2020","unstructured":"Guzm\u00e1n-Ruiz R, Tercero-Alc\u00e1zar C, Rabanal-Ruiz Y, et al. Adipose tissue depot-specific intracellular and extracellular cues contributing to insulin resistance in obese individuals. FASEB J. 2020;34(6):7520\u201339.","journal-title":"FASEB J"},{"issue":"6","key":"10098_CR15","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.2337\/db12-0976","volume":"62","author":"E Ahlqvist","year":"2013","unstructured":"Ahlqvist E, Osmark P, Kuulasmaa T, et al. Link Between GIP and Osteopontin in Adipose Tissue and Insulin Resistance. Diabetes 1 June. 2013;62(6):2088\u201394.","journal-title":"Diabetes 1 June"},{"key":"10098_CR16","doi-asserted-by":"crossref","unstructured":"Campbell JE, Beaudry JL, Svendsen B et all.; GIPR Is Predominantly Localized to Nonadipocyte Cell Types Within White Adipose Tissue. Diabetes. 2022;71(5):1115\u20131127.","DOI":"10.2337\/db21-1166"},{"issue":"2","key":"10098_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1677\/joe.0.1300267","volume":"130","author":"J Oben","year":"1991","unstructured":"Oben J, Morgan L, Fletcher J, Marks V. Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7\u201336) amide, on fatty acid synthesis in explants of rat adipose tissue. J Endocrinol. 1991;130(2):267\u201372.","journal-title":"J Endocrinol"},{"issue":"10","key":"10098_CR18","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.2337\/db14-0302","volume":"63","author":"D Beiroa","year":"2014","unstructured":"Beiroa D, Imbernon M, Gallego R, et al. GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK. Diabetes. 2014;63(10):3346\u201358.","journal-title":"Diabetes"},{"issue":"4","key":"10098_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41574-022-00783-3","volume":"19","author":"R Hammoud","year":"2023","unstructured":"Hammoud R, Drucker DJ. Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1. Nat Rev Endocrinol. 2023;19(4):201\u201316.","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"10098_CR20","doi-asserted-by":"publisher","first-page":"8557","DOI":"10.1074\/jbc.M609088200","volume":"282","author":"SJ Kim","year":"2007","unstructured":"Kim SJ, Nian C, McIntosh CH. Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes. A role for a protein kinase B, LKB1, and AMP-activated protein kinase cascade. J Biol Chem. 2007;282(12):8557\u201367.","journal-title":"J Biol Chem"},{"issue":"7","key":"10098_CR21","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nm727","volume":"8","author":"K Miyawaki","year":"2002","unstructured":"Miyawaki K, Yamada Y, Ban N, et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med. 2002;8(7):738\u201342.","journal-title":"Nat Med"},{"key":"10098_CR22","doi-asserted-by":"crossref","unstructured":"Yu X, Chen S, Funcke JB, et all.; The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice. Cell Metab. 2025;37(1):187\u2013e2047.","DOI":"10.1016\/j.cmet.2024.11.003"},{"issue":"3","key":"10098_CR23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.molmet.2017.01.006","volume":"6","author":"S Shimazu-Kuwahara","year":"2017","unstructured":"Shimazu-Kuwahara S, Harada N, Yamane S, et al. Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in ob\/ob mice. Mol Metab. 2017;6(3):288\u201394.","journal-title":"Mol Metab"},{"issue":"5","key":"10098_CR24","doi-asserted-by":"publisher","first-page":"E414","DOI":"10.1152\/ajpendo.00418.2014","volume":"308","author":"S Chen","year":"2015","unstructured":"Chen S, Okahara F, Osaki N, Shimotoyodome A. Increased GIP signaling induces adipose inflammation via a HIF-1\u03b1-dependent pathway and impairs insulin sensitivity in mice. Am J Physiol Endocrinol Metab. 2015;308(5):E414\u201325.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"10098_CR25","doi-asserted-by":"publisher","first-page":"e278","DOI":"10.1038\/nutd.2017.28","volume":"7","author":"T Wang","year":"2017","unstructured":"Wang T, Ma X, Tang T, et al. The effect of glucose-dependent insulinotropic polypeptide (GIP) variants on visceral fat accumulation in Han Chinese populations. Nutr Diabetes. 2017;7(5):e278.","journal-title":"Nutr Diabetes"},{"issue":"12","key":"10098_CR26","doi-asserted-by":"publisher","first-page":"E1008","DOI":"10.1152\/ajpendo.00345.2015","volume":"309","author":"MO Boylan","year":"2015","unstructured":"Boylan MO, Glazebrook PA, Tatalovic M, Wolfe MM. Gastric inhibitory polypeptide immunoneutralization attenuates development of obesity in mice. Am J Physiol Endocrinol Metab. 2015;309(12):E1008\u201318.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10098_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12933-023-01940-2","volume":"22","author":"S Sachs","year":"2023","unstructured":"Sachs S, G\u00f6tz A, Finan B, et al. GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease. Cardiovasc Diabetol. 2023;22(1):217.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10098_CR28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2337\/db10-0902","volume":"61","author":"\u00d6 G\u00f6gebakan","year":"2012","unstructured":"G\u00f6gebakan \u00d6, Andres J, Biedasek K, et al. Glucose-dependent insulinotropic polypeptide reduces fat-specific expression and activity of 11\u03b2-hydroxysteroid dehydrogenase type 1 and inhibits release of free fatty acids. Diabetes. 2012;61(2):292\u2013300.","journal-title":"Diabetes"},{"issue":"9","key":"10098_CR29","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.2337\/db10-0098","volume":"59","author":"M Asmar","year":"2010","unstructured":"Asmar M, Simonsen L, Madsbad S, et al. Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans. Diabetes. 2010;59(9):2160\u20133.","journal-title":"Diabetes"},{"issue":"8","key":"10098_CR30","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1210\/jc.2016-1933","volume":"101","author":"M Asmar","year":"2016","unstructured":"Asmar M, Simonsen L, Asmar A. Jet al.; Insulin Plays a Permissive Role for the Vasoactive Effect of GIP Regulating Adipose Tissue Metabolism in Humans. J Clin Endocrinol Metab. 2016;101(8):3155\u201362.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10098_CR31","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1210\/clinem\/dgac191","volume":"107","author":"T Saari","year":"2022","unstructured":"Saari T, Koffert J, Honka H, et al. Obesity-associated Blunted Subcutaneous Adipose Tissue Blood Flow After Meal Improves After Bariatric Surgery. J Clin Endocrinol Metab. 2022;107(7):1930\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10098_CR32","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.2337\/db17-0480","volume":"66","author":"M Asmar","year":"2017","unstructured":"Asmar M, Asmar A, Simonsen L, et al. The Gluco- and Liporegulatory and Vasodilatory Effects of Glucose-Dependent Insulinotropic Polypeptide (GIP) Are Abolished by an Antagonist of the Human GIP Receptor. Diabetes. 2017;66(9):2363\u201371.","journal-title":"Diabetes"},{"key":"10098_CR33","doi-asserted-by":"crossref","unstructured":"Stensen S, Gasbjerg L, Krogh LL, et al. Effects of endogenous GIP in patients with type 2 diabetes. Eur J Endocrinol. Jul 2021;185(1):33\u201345.","DOI":"10.1530\/EJE-21-0135"},{"issue":"3","key":"10098_CR34","doi-asserted-by":"publisher","first-page":"E224","DOI":"10.1152\/ajpendo.00347.2016","volume":"312","author":"SK Thondam","year":"2017","unstructured":"Thondam SK, Daousi C, Wilding JP, et al. Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive response. Am J Physiol Endocrinol Metab. 2017;312(3):E224\u201333.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"10098_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/ijo.2013.73","volume":"38","author":"M Asmar","year":"2014","unstructured":"Asmar M, Simonsen L, Arngrim N, et al. Glucose-dependent insulinotropic polypeptide has impaired effect on abdominal, subcutaneous adipose tissue metabolism in obese subjects. Int J Obes (Lond). 2014;38(2):259\u201365.","journal-title":"Int J Obes (Lond)"},{"issue":"5","key":"10098_CR36","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1038\/nutd.2016.15","volume":"6","author":"M Asmar","year":"2016","unstructured":"Asmar M, Arngrim N, Simonsen L, et al. The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss. Nutr Diabetes. 2016;6(5):e208.","journal-title":"Nutr Diabetes"},{"issue":"6","key":"10098_CR37","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","volume":"132","author":"LL Baggio","year":"2007","unstructured":"Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007;132(6):2131\u201357.","journal-title":"Gastroenterology"},{"issue":"3","key":"10098_CR38","doi-asserted-by":"publisher","first-page":"e230361","DOI":"10.1530\/JOE-23-0361","volume":"261","author":"S Kagdi","year":"2024","unstructured":"Kagdi S, Lyons SA, Beaudry JL. The interplay of glucose-dependent insulinotropic polypeptide in adipose tissue. J Endocrinol. 2024;261(3):e230361.","journal-title":"J Endocrinol"},{"issue":"10","key":"10098_CR39","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s11883-014-0441-1","volume":"16","author":"P Boonchaya-anant","year":"2014","unstructured":"Boonchaya-anant P, Apovian CM. Metabolically healthy obesity\u2013does it exist? Curr Atheroscler Rep. 2014;16(10):441.","journal-title":"Curr Atheroscler Rep"},{"issue":"2","key":"10098_CR40","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41576-021-00414-z","volume":"23","author":"RJF Loos","year":"2022","unstructured":"Loos RJF, Yeo GSH. The genetics of obesity: from discovery to biology. Nat Rev Genet. 2022;23(2):120\u201333.","journal-title":"Nat Rev Genet"},{"key":"10098_CR41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fendo.2016.00030","volume":"7","author":"SS Choe","year":"2016","unstructured":"Choe SS, Huh JY, Hwang IJ. Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders. Front Endocrinol (Lausanne). 2016;7:30.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10098_CR42","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.clnu.2018.07.005","volume":"38","author":"J Konieczna","year":"2019","unstructured":"Konieczna J, Abete I, Galm\u00e9s AM, et al. PREDIMED-Plus Investigators. Body adiposity indicators and cardiometabolic risk: Cross-sectional analysis in participants from the PREDIMED-Plus trial. Clin Nutr. 2019;38(4):1883\u201391.","journal-title":"Clin Nutr"},{"issue":"8","key":"10098_CR43","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/mnfr.200700048","volume":"51","author":"I Nitz","year":"2007","unstructured":"Nitz I, Fisher E, Weikert C, et al. Association analyses of GIP and GIPR polymorphisms with traits of the metabolic syndrome. Mol Nutr Food Res. 2007;51(8):1046\u201352.","journal-title":"Mol Nutr Food Res"},{"issue":"11","key":"10098_CR44","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/ng.686","volume":"42","author":"EK Speliotes","year":"2010","unstructured":"Speliotes EK, Willer CJ, Berndt SI, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42(11):937\u201348.","journal-title":"Nat Genet"},{"issue":"2","key":"10098_CR45","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/ng.521","volume":"42","author":"R Saxena","year":"2010","unstructured":"Saxena R, Hivert MF, Langenberg C, et al. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet. 2010;42(2):142\u20138.","journal-title":"Nat Genet"},{"key":"10098_CR46","doi-asserted-by":"publisher","first-page":"1170181","DOI":"10.3389\/fmolb.2023.1170181","volume":"10","author":"GO Austin","year":"2023","unstructured":"Austin GO, Tomas A. Variation in responses to incretin therapy: Modifiable and non-modifiable factors. Front Mol Biosci. 2023;10:1170181.","journal-title":"Front Mol Biosci"},{"key":"10098_CR47","doi-asserted-by":"publisher","first-page":"101139","DOI":"10.1016\/j.molmet.2020.101139","volume":"46","author":"JE Campbell","year":"2021","unstructured":"Campbell JE. Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms. Mol Metab. 2021;46:101139.","journal-title":"Mol Metab"},{"issue":"4","key":"10098_CR48","first-page":"1","volume":"18","author":"M Gharipour","year":"2022","unstructured":"Gharipour M, Nezafati P, Sadeghian L, et al. Precision medicine and metabolic syndrome. ARYA Atheroscler. 2022;18(4):1\u201310.","journal-title":"ARYA Atheroscler"},{"issue":"4","key":"10098_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/proteomes13040067","volume":"13","author":"PM Bertalan","year":"2025","unstructured":"Bertalan PM, Nokhoijav E, Pap \u00c1, et al. Comprehensive Insights into Obesity and Type 2 Diabetes from Protein Network, Canonical Pathway, Phosphorylation and Antimicrobial Peptide Signatures of Human Serum. Proteomes. 2025;13(4):67.","journal-title":"Proteomes"},{"issue":"16","key":"10098_CR50","doi-asserted-by":"publisher","first-page":"8650","DOI":"10.3390\/ijms25168650","volume":"25","author":"M De Fano","year":"2024","unstructured":"De Fano M, Malara M, Vermigli C, Murdolo G. Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance. Int J Mol Sci. 2024;25(16):8650.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10098_CR51","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11154-013-9261-9","volume":"14","author":"L Rui","year":"2013","unstructured":"Rui L. Brain regulation of energy balance and body weight. Rev Endocr Metab Disord. 2013;14(4):387\u2013407.","journal-title":"Rev Endocr Metab Disord"},{"issue":"12","key":"10098_CR52","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.tem.2023.08.014","volume":"34","author":"A Furlan","year":"2023","unstructured":"Furlan A, Petrus P. Brain-body communication in metabolic control. Trends Endocrinol Metab. 2023;34(12):813\u201322.","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"10098_CR53","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1365-2265.2006.02474.x","volume":"64","author":"T Ronti","year":"2006","unstructured":"Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf). 2006;64(4):355\u201365.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10098_CR54","doi-asserted-by":"publisher","first-page":"595","DOI":"10.4093\/dmj.2023.0011","volume":"47","author":"SM An","year":"2023","unstructured":"An SM, Cho SH, Yoon JC. Adipose Tissue and Metabolic Health. Diabetes Metab J. 2023;47(5):595\u2013611.","journal-title":"Diabetes Metab J"},{"issue":"2","key":"10098_CR55","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0196-9781(94)90016-7","volume":"15","author":"AM Kaplan","year":"1994","unstructured":"Kaplan AM, Vigna SR. Gastric inhibitory polypeptide (GIP) binding sites in rat brain. Peptides. 1994;15(2):297\u2013302.","journal-title":"Peptides"},{"issue":"8","key":"10098_CR56","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.2337\/dbi24-0026","volume":"74","author":"RJ Samms","year":"2025","unstructured":"Samms RJ, Sloop KW. A Contemporary Rationale for Agonism of the GIP Receptor in the Treatment of Obesity. Diabetes. 2025;74(8):1326\u201333.","journal-title":"Diabetes"},{"issue":"1","key":"10098_CR57","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1186\/s12967-025-06656-3","volume":"23","author":"J Liu","year":"2025","unstructured":"Liu J, Jing C, Guo Y, et al. The central signaling pathways related to metabolism-regulating hormones of the gut-brain axis: a review. J Transl Med. 2025;23(1):648.","journal-title":"J Transl Med"},{"key":"10098_CR58","doi-asserted-by":"publisher","first-page":"7949582","DOI":"10.1155\/2017\/7949582","volume":"2017","author":"R Maldonado-Ruiz","year":"2017","unstructured":"Maldonado-Ruiz R, Fuentes-Mera L, Camacho A. Central Modulation of Neuroinflammation by Neuropeptides and Energy-Sensing Hormones during Obesity. Biomed Res Int. 2017;2017:7949582.","journal-title":"Biomed Res Int"},{"issue":"7","key":"10098_CR59","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.3390\/cells10071584","volume":"10","author":"VI Alexaki","year":"2021","unstructured":"Alexaki VI. The Impact of Obesity on Microglial Function: Immune, Metabolic and Endocrine Perspectives. Cells. 2021;10(7):1584.","journal-title":"Cells"},{"key":"10098_CR60","doi-asserted-by":"publisher","first-page":"171198","DOI":"10.1016\/j.peptides.2024.171198","volume":"176","author":"A Liskiewicz","year":"2024","unstructured":"Liskiewicz A, M\u00fcller TD. Regulation of energy metabolism through central GIPR signaling. Peptides. 2024;176:171198.","journal-title":"Peptides"},{"issue":"4","key":"10098_CR61","doi-asserted-by":"publisher","first-page":"E472","DOI":"10.1152\/ajpendo.00250.2023","volume":"326","author":"S Buller","year":"2024","unstructured":"Buller S, Blouet C. Brain access of incretins and incretin receptor agonists to their central targets relevant for appetite suppression and weight loss. Am J Physiol Endocrinol Metab. 2024;326(4):E472\u201380.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10098_CR62","doi-asserted-by":"publisher","first-page":"171380","DOI":"10.1016\/j.peptides.2025.171380","volume":"187","author":"CJ Bailey","year":"2025","unstructured":"Bailey CJ, Flatt PR, Conlon JM. Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities. Peptides. 2025;187:171380.","journal-title":"Peptides"},{"issue":"2","key":"10098_CR63","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s42255-023-00966-w","volume":"6","author":"MM V\u00e9niant","year":"2024","unstructured":"V\u00e9niant MM, Lu SC, Atangan L, et al. A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings. Nat Metab. 2024;6(2):290\u2013303.","journal-title":"Nat Metab"},{"issue":"7","key":"10098_CR64","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1210\/jc.2019-00008","volume":"104","author":"NC Bergmann","year":"2019","unstructured":"Bergmann NC, Lund A, Gasbjerg LS, et al. Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men Without Diabetes. J Clin Endocrinol Metab. 2019;104(7):2953\u201360.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10098_CR65","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.2337\/dci24-0003","volume":"47","author":"DJ Drucker","year":"2024","unstructured":"Drucker DJ. Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity. Diabetes Care. 2024;47(11):1873\u201388.","journal-title":"Diabetes Care"},{"issue":"9","key":"10098_CR66","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1056\/NEJMoa2504214","volume":"393","author":"AM Jastreboff","year":"2025","unstructured":"Jastreboff AM, Ryan DH, Bays HE, et al. Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity - A Phase 2 Trial. N Engl J Med. 2025;393(9):843\u201357.","journal-title":"N Engl J Med"},{"issue":"7","key":"10098_CR67","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.cmet.2024.05.010","volume":"36","author":"A Regmi","year":"2024","unstructured":"Regmi A, Aihara E, Christe ME, et al. Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor. Cell Metab. 2024;36(7):1534\u2013e15497.","journal-title":"Cell Metab"},{"issue":"2","key":"10098_CR68","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/ejendo\/lvae151","volume":"192","author":"S Brachs","year":"2025","unstructured":"Brachs S, Soll D, Beer F, et al. Hormonal regulation of human adipose tissue lipolysis: impact of adipose GIP system in overweight and obesity. Eur J Endocrinol. 2025;192(2):91\u20139.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10098_CR69","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205\u201316.","journal-title":"N Engl J Med"},{"issue":"2","key":"10098_CR70","first-page":"117","volume":"389","author":"AM Jastreboff","year":"2023","unstructured":"Jastreboff AM, Rosenstock J, Kaplan LM, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity \u2014 A Phase 2 Trial. N Engl J Med. 2023;389(2):117\u201328.","journal-title":"N Engl J Med"},{"key":"10098_CR71","doi-asserted-by":"crossref","unstructured":"Hropot T, Herman R, Janez A et all.; Brown Adipose Tissue: A New Potential Target for Glucagon-like Peptide 1 Receptor Agonists in the Treatment of Obesity. International Journal of Molecular Sciences. 2023; 24(10):8592.","DOI":"10.3390\/ijms24108592"},{"key":"10098_CR72","doi-asserted-by":"crossref","unstructured":"Spezani R, Marcondes-de-Castro IA, Marinho TS et all.; Cotadutide improves brown adipose tissue thermogenesis in obese mice. Biochem Pharmacol. 2023;217:115852.","DOI":"10.1016\/j.bcp.2023.115852"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-026-10098-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-026-10098-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-026-10098-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:38:51Z","timestamp":1792640331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-026-10098-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":72,"alternative-id":["10098"],"URL":"https:\/\/doi.org\/10.1007\/s11154-026-10098-7","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}